Amgen, Inc.

Amgen, Inc.

Amgen, Inc.

Overview
Date Founded

1980

Headquarters

One Amgen Center Drive,Thousand Oaks, CA 91320-1799

Type of Company

Public

Employees (Worldwide)

23.4K

Industries

Biotechnology
Hospitals & Patient Services

Company Description

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Contact Data
Trying to get in touch with decision makers at Amgen, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

Executive Director & Head of Global Media Relations

Senior Vice President, Manufacturing

Executive Director

Executive Vice President & Chief Financial Officer

Executive Vice President, General Counsel & Secretary

Senior Vice President & Chief Compliance Officer

Senior Vice President & Chief Information Officer

Senior Vice President, General Manager, US General Medicine

Executive Vice President, Human Resources

Board of Directors

Director Healthcare at Warburg Pincus LLC

President at USC Norris Comprehensive Cancer Center

President, Chief Executive Officer & Director at Carbon, Inc.

Chair, Governance at Los Angeles Philharmonic Association

Operating Partner at FFL Partners LLC

Managing Director at General Wireless Operations, Inc.

Founder at Dragonfly Therapeutics, Inc.

Chairman & Chief Executive Officer at Phillips 66

Director at Oregon Health & Science University - Knight Cancer Institute

Professor at Duke University

Paths to Amgen, Inc.
Potential Connections via
Relationship Science
You
Amgen, Inc.
Owners & Shareholders
Details Hidden

CWGI is the investment adviser to the American Funds Group, a family of 30 funds marketed to individuals exclusively through financial advisers and other intermediaries. American Funds are also used as investment vehicles for 401ks, other retirement plans, variable annuities and 529 college savings plans. The funds have the following characteristics: (1) a long-term, value-oriented approach; (2) long-established, global research; (3) a multiple portfolio counselor system that combines teamwork with individual accountability; (4) experienced, long-tenured investment professionals; and (5) a commitment to low operating expenses, among the lowest in the fund industry. CWGI uses a Multiple Portfolio Counselor System wherein the assets of each fund are divided into smaller, more manageable portions. Research analysts typically manage a segment as well, bringing their expertise directly to bear on the fund's results and portfolio counselors are free to make their own decisions. Investment decisions are based on internal research.

Details Hidden

FMR may use a variety of methods of security analysis in managing client assets to select investments including fundamental analysis, quantitative analysis and cyclical analysis. They may also use general macro-economic analysis as a component of its security analysis methods. In addition to relying on public financial statement information, the firm may use extensive corporate visits and interviews with issuer management teams in conducting research. When it comes to the management of the client assets according to the investment objectives, FMR may use a variety of investment strategies including, but not limited to, investing in stocks and other public and private equity securities, bonds and other debt securities of all types and repurchase agreements for those securities, real estate related investments of all types, derivatives, currency spot and forward trading, other investment funds, including exchange traded funds and FMR's or its affiliates' central funds. They may also engage in securities lending to parties such as broker-dealers or other institutions.

Details Hidden

PRIMECAP Management aims to provide superior long-term investment results by utilizing fundamental research and bottom-up stock picking to construct portfolios. The firm looks for stocks that will outperform the market over a three to five-year horizon. PRIMECAP Management does not have a committee or small group that decides on whether or not to invest in an idea. Each portfolio manager makes an individual decision whether or not to invest in new ideas.

Recent Transactions
Details Hidden

Amgen, Inc. purchases Celgene Corp. /OTEZLA Assets from Celgene Corp.

Details Hidden

Amgen, Inc. purchases Nuevolution AB

Details Hidden

Amgen, Inc. purchases Kirin-Amgen, Inc. from Kirin Holdings Co., Ltd.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Legal Advisor

Advised onAmgen, Inc. purchases Onyx Pharmaceuticals, Inc.

Accountant

Advised onAmgen, Inc. purchases Immunex Corp.

Legal Advisor

Advised onAmgen, Inc. purchases Immunex Corp.

Legal Advisor

Advised onAmgen, Inc. purchases Onyx Pharmaceuticals, Inc.

Legal Advisor

Advised onAmgen, Inc. purchases Onyx Pharmaceuticals, Inc.

Legal Advisor

Advised onAmgen, Inc. purchases Onyx Pharmaceuticals, Inc.

Advisors & Consultants
Advisor

President & Managing Director at Morgan Stanley Investment Management, Inc.

Advisor

Chief Financial Officer at Platinum Equity Advisors LLC

Legal Advisor

Co-Managing Partner at Wilmer Cutler Pickering Hale and Dorr LLP

Clients

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

DaVita is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of September 30, 2012, DaVita operated or provided administrative services at 1,912 outpatient dialysis centers in 43 states in the United States, serving approximately 150,000 patients, and at 24 centers in five countries outside of the United States that serve approximately 1,000 patients.

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company is headquartered in Chesterbrook, PA.

Key Stats and Financials As of 2019
Market Capitalization
$117B
Total Enterprise Value
$168B
Earnings Per Share
$12.88
Revenue
$23.3B
Net Profit
$7.84B
Total Equity
$9.67B
TEVNet Income
21.47x
Debt TEV
0.18x
Enterprise Value Sales
7.24x
Total Debt
$30.4B
EBITDAMargin
50.64%
Enterprise Value EBITDAOperating
14.25x
EBITDA
$11.8B
Five Year Compounded Annual Growth Rate Of Revenue
3.03%
Three Year Compounded Annual Growth Rate Of Revenue
0.84%
Non-Profit Donations & Grants
Political Donations
$200
2014
$200
2014
$2,500
2014
Investments
Details Hidden

Oxford Nanopore Technologies Ltd. develops proprietary technology platform for the electronic analysis of single molecules. It also develops instruments like GridIONTM and MinIONTM which are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. The firm's platform has a broad range of potential applications, including scientific research, personalized medicine, crop science and security and defence. The company was founded by Gordon Sanghera, Spike Willcocks and John Hagan Pryce Bayley in 2005 and is headquartered in Oxford, the United Kingdom.

Details Hidden

Kezar Life Sciences, Inc. is a clinical-stage biotechnology company, which discovers and develops novel small molecule therapeutics to treat autoimmunity and cancer. The firm specializes in the areas of protein degradation and protein secretion to discover & develop novel therapies for the treatment of serious and unmet medical needs. Its product include KZR-616, an immunoproteasome inhibitor, has completed testing in healthy volunteers. The company was founded by John Fowler, Christopher J. Kirk and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.

Details Hidden

Gamida Cell Ltd. is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure blood cancer and rare serious hematologic diseases. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.

Investors
Details Hidden

Co-Founder at Longitude Capital Management Co. LLC

Details Hidden

Life Peer at United Kingdom House of Lords

Details Hidden

Co-Founder at De Novo Ventures

Suppliers
Healthpeak Properties, Inc. Trusts & Funds | Irvine, CA

Healthpeak Properties, Inc. is a real estate investment trust, which invests primarily in real estate serving the healthcare industry in the United States. It acquires, develops, leases, sells, and manages healthcare real estate and provides mortgage and other financing to healthcare providers. It operates through the following business segments: Senior Housing Triple-Net, Senior Housing Operating Portfolio (SHOP), Life Science, and Medical Office. The Senior Housing Triple-Net and Operating Portfolio segments manage senior housing facilities, which include independent living, assisted living and memory care facilities, care homes, and continuing care retirement communities by utilizing triple-net leases and RIDEA structures. The Life Science segment contains laboratory and office space primarily for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Medical Office segment includes pharmacies, hospital ancillary service space, and outpatient services such as diagnostic centers, rehabilitation clinics, and day-surgery operating rooms. The company was founded in March 1985 and is headquartered in Irvine, CA.

Immunogen Inc. Medical Support Services | Waltham, MA

ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded in March 1981 and is headquartered in Waltham, MA.

Harvard Bioscience, Inc. Industrial Machinery & Manufacturing | Holliston, MA

Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Competitors
Regeneron Pharmaceuticals, Inc. Pharmaceuticals - Tarrytown, New York

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Mylan NV Pharmaceuticals - Hatfield, United Kingdom

Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.

Awards & Honors
Rank #130
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #130
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Amgen, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Amgen, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Amgen, Inc..